Core Viewpoint - The article emphasizes the importance of accelerating the development of the biopharmaceutical industry in China through enhanced technological innovation and policy support, aiming to produce high-quality and effective new drugs to improve public health [2][3][4]. Group 1: Government Initiatives - The Chinese government is committed to increasing high-quality technological supply and policy support for the biopharmaceutical industry, focusing on innovation and the role of enterprises in driving development [2]. - There is a call for collaboration in research and development, targeting new drug projects with high clinical value and transformation potential, alongside support for talent cultivation and international cooperation [2][3]. Group 2: Industry Development - The biopharmaceutical industry is recognized as a strategic emerging industry with significant market potential, and there is a strong emphasis on original innovation and tackling key technologies [3][4]. - The government aims to enhance the integration of artificial intelligence in various stages of drug development, clinical trials, and production processes to improve efficiency and outcomes [3]. Group 3: Support for Traditional Medicine - There is a focus on promoting the modernization and industrialization of traditional Chinese medicine by applying modern scientific theories and technologies to deepen research in its foundational theories and treatment methods [4].
李强在北京调研生物医药产业发展时强调 加大高质量科技供给和政策支持 着力推动生物医药产业提质升级
证监会发布·2025-08-21 02:32